
Bridging the Gap in Newborn Eye Care: How Technology Is Transforming Early Detection of Retinopathy of Prematurity
KMK Rajendran, Business Head – India Operations at Forus Health
In India, thousands of newborns face the risk of lifelong visual impairment or blindness from a condition like Retinopathy of Prematurity (ROP), which is largely preventable with timely screening and intervention. What concerns me most is that in many cases, the challenge is not the absence of a solution, but the lack of accessibility and timely intervention.
ROP is a potentially sight-threatening eye condition that affects premature and low-birth-weight infants who require NICU care. It occurs when the blood vessels in an infant’s developing retina grow abnormally due to unmonitored supply of oxygen. If left undetected and untreated, the condition can progress rapidly, leading to retinal detachment and permanent blindness. What makes ROP particularly concerning is that it can develop without any visible symptoms in its early stages, making timely screening critical.
India faces a significant ROP burden. According to a 2026 review published in Indian Pediatrics, approximately 7.5 lakh infants require ROP screening every year. Of these, an estimated 2.25 lakh are expected to develop ROP, with 50,000–75,000 potentially requiring treatment.
However, the challenge extends beyond the prevalence of the condition. Access to timely screening remains a significant gap in our country’s neonatal healthcare ecosystem. The same review highlights that only around 30% of accredited NICUs have arrangements for ROP screening. Across different healthcare settings, estimates of eligible newborns receiving screening range from just 18% to 90%.
There are several reasons behind this gap: a shortage of trained ROP specialists, limited availability of specialized retinal imaging equipment, geographical barriers and the cost of establishing screening infrastructure. In many smaller hospitals and semi-urban and rural healthcare facilities, access to specialist eye care remains limited. Consequently, babies who need timely screening may be missed or referred too late, limiting the opportunities to preserve their vision.
I strongly believe that technology has an important role to play in addressing this gap. Wide-field digital retinal imaging enables trained healthcare personnel to capture detailed images of an infant’s retina, which can then be reviewed by retinal specialists. When integrated with telemedicine, this approach can help extend specialist expertise beyond major tertiary hospitals.
Traditionally, established imaging systems have played an important role in ROP screening. However, their size and high capital costs make large-scale deployment challenging, particularly in resource- and space-constrained healthcare facilities in India. Recognizing this need, our team at Forus Health developed the 3nethra neo, with the objective of making neonatal retinal imaging more accessible through a relatively cost-effective, portable and ergonomically designed solution.
Our 3nethra neo device variants cater to varying needs of the healthcare service provider ensuring it’s accessible and affordable to all kinds of NICU units. For example of 3nethra neo HD gives high definition images of retina with 150 degree FOV. 3nethra neo HD FA design besides having a compact handheld form factor with high-resolution imaging capabilities, offers a 150-degree field of view, with a 20-megapixel camera sensor and Fluorescein Angiography (FA) capability, enabling detailed visualization of retinal vascular abnormalities, including peripheral neovascularization and active leakage.
The portability of our 3nethra neo devices make it suitable for deployment across NICUs, hospitals, operating rooms and mobile screening settings, addressing two important barriers: accessibility and cost.
Importantly, compatibility with Forus Health’s FH TeleCare platform enables captured retinal images to be shared for remote specialist consultations. Healthcare personnel at NICUs, with appropriate basic training, can use the device to capture retinal images and share reports with ROP specialists for review and further guidance. This helps bridge geographical gaps in neonatal eye care and enables timely intervention without geographical accessibility becoming a barrier.
Beyond imaging, Forus Health is advancing ROP screening through FH-POISE™ROP-AI, an AI-powered solution designed to support specialists in reviewing cases at scale. Going beyond simply detecting ROP, the system helps characterize the condition by assessing its stage, zone and plus or pre-plus disease. It provides first-pass indications, heatmaps and reports, flags urgent cases for prompt specialist review and prioritizes the most informative retinal images for clinical assessment. Designed to work offline on a standard computer without requiring a GPU or internet connection, ROP-AI aims to make expert review more efficient and accessible, helping address the growing demand for timely ROP screening and follow-up. For a country like India, where neonatal healthcare infrastructure varies significantly between urban centres and underserved regions, portability and affordability are not simply product features; they are important considerations in expanding access.
By making neonatal retinal imaging more portable, ergonomic and accessible, technology can help bring screening closer to where newborns receive care. Because when it comes to protecting a child’s vision, early detection should never be a matter of where they are born.





